Javier, Esterlita L.
HRN: 03-08-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/27/2023
10/04/2023
IVT
1.5grams
Q6hrs
ABSCESS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes